What AYMES does

AYMES International Limited is a UK-based private manufacturer of Oral Nutritional Supplements (ONS) used in the management of disease-related malnutrition. Founded in 2013 and registered in England and Wales (Company No. 06603123), the company is headquartered in Leek, Staffordshire, with a secondary office in Dublin, Ireland, and operates as a remote-first organisation with approximately 30 employees across the UK and Europe.

The company's product range centres on two platforms: ActaGain, a ready-to-drink and ready-to-eat range priced at 99p per unit for the 1.5 Complete SKU from December 2025, and ActaSolve, a powdered format. It also offers the ActaJuni pediatric line and plant-based variants. Products are ACBS-approved for NHS prescribing and are dispensed through the FP10/GP10 prescription system, supported by a 48-hour free sample service for clinicians and the AYMES Academy education platform.

AYMES monetises almost exclusively via NHS prescriptions across UK Clinical Commissioning Groups, with secondary activity in Ireland. It positions itself on cost-effectiveness — citing 8p per gram of protein for ActaGain Protein Compact versus 9–15p for competitors — and reports £230m of cumulative NHS savings from March 2013 to June 2025. Operational credentials include ISO 9001, ISO 14001, and B-Corp (June 2024) certifications, and the company was named in the Sunday Times Best Places to Work 2026.

Name

AYMES

Legal name

AYMES International Limited

Website

https://aymes.com

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

11–50 employees

Short description

AYMES International Limited is a UK-based manufacturer of Oral Nutritional Supplements (ONS) for disease-related malnutrition, selling ACBS-approved products through NHS prescriptions and serving healthcare professionals in the UK and Ireland.

Ownership category

akta.pro rank

Product category

Clinical Nutrition / Oral Nutritional Supplements

NAICS

Dairy Product Manufacturing (3115), Dairy Product (except Frozen) Manufacturing (31151)

SIC

Food And Kindred Products (2000), Dairy Products (2020)

akta.pro primary industry

Medical Nutrition & Meal Replacement (RTD, Bars, Powders) (CRADAGAN)

akta.pro secondary industry

Infant Formula & Specialized Dairy Nutrition Manufacturing (AFAKAKAJ)

Keywords

• Oral nutritional supplements
• Clinical nutrition products
• Disease-related malnutrition
• NHS prescription supplements
• Medical nutrition manufacturing

Headquarters

HQ city

Kensington

HQ country

United Kingdom

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Others

Revenue model

1. NHS Product Sales: AYMES oral nutritional supplements are sold to the NHS through prescription (FP10/GP10) and direct supply. Products are prescribed by healthcare professionals for patients with or at risk of disease-related malnutrition.
2. Sample Service: Free samples provided to healthcare professionals and patients to trial products before prescription. Available for fast, free delivery within 48 hours.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

AYMES manufactures and supplies a comprehensive range of oral nutritional supplements (ONS) for the dietary management of disease-related malnutrition, organised under two main product families: ActaGain (ready-to-drink and ready-to-eat formats) and ActaSolve (powdered formats). Products are ACBS-approved for NHS prescribing and sold primarily through the NHS FP10/GP10 prescription system, supported by a free sample service for healthcare professionals and an educational platform (AYMES Academy).

Product overview

AYMES is a specialist producer of oral nutritional supplements (ONS) designed for the dietary management of disease-related malnutrition. The company offers a comprehensive portfolio organized under two main product families: ActaGain (ready-to-drink and ready-to-eat formats including compact bottles, juices, and cremes) and ActaSolve (powdered formats including milkshakes, savoury, smoothie, and protein variants). The product range spans various caloric densities (1.5-2.4 kcal/ml) and protein levels (including high-protein options like ActaGain Protein Compact with 20g protein per 125ml), with specialized products for paediatric patients (ActaJuni/Actajuni Shake) and plant-based options (Actagain 1.5 Plant Powered). AYMES serves primarily healthcare professionals and the NHS, offering professional education through AYMES Academy and product sampling services.

Differentiator

Problem solved

Functional benefit

Brands

• ActaGain: Product line for ready-to-drink and ready-to-eat oral nutritional supplements, including ActaGain 1.5 Complete, ActaGain 2.0, ActaGain 2.4, ActaGain Protein Compact, ActaGain Protein Shot, ActaGain Juce, and Actagain Creme.
• ActaSolve
• ActaJuni
• AYMES Academy
• AYMES Research Hub

Products and services

• ActaGain 1.5 Complete Highly prescribed ready-to-drink ONS providing 1.5kcal/ml, ACBS approved, available in Tetra Pak packaging for HCPs prescribing on FP10/GP10.
• ActaGain 1.5 Juce

Quantifiable outcome

• NHS cost savings of £230 million through use of cost-effective ONS products
• +4 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Five partnerships are on record, tiered minor and core.

• UNICEFminorStrategic or Co-development Partner · 11 June 2024AYMES supports UNICEF through product donations as part of their charitable giving program, pledge 5% of profits to charitable causes in the UK.
• Tetra PakcoreTechnology or IntegrationPartnership for sustainable packaging solutions. Tetra Pak cartons use 75% less plastic than standard ONS bottles, are made from 63% plant-based materials, and contribute to 11% reduction in carbon emissions.
• Nightingale Hammerson's ReachminorStrategic or Co-development PartnerFood-first initiative partnership creating fortified food recipes (fortified porridge, soup, milkshake, pasta, custard) for patients to support nutritional intake through food-based approaches.
• The Bread and Butter ThingminorStrategic or Co-development PartnerCharitable partnership through AYMES Give Back Day, supporting community food access initiatives.
• Dougie Mac HospiceminorStrategic or Co-development PartnerCharitable partnership through AYMES Employee Charity Day, supporting hospice care.

Scale indicators8 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Fresenius Kabi: Global medical nutrition leader whose Fresubin ONS portfolio (including Fresubin Pro Compact) directly competes with AYMES on NHS formularies. They are the primary benchmark AYMES compares pricing against.
• Nutricia (Danone): Medical nutrition division of Danone producing Fortisip, the long-standing dominant UK ONS brand. Direct competitor on FP10/GP10 prescribing, with Fortisip Compact Protein priced at 15p/g protein in AYMES' comparison.
• Vitaflo: UK-based medical nutrition company focused on disease-specific and paediatric nutrition, ACBS-approved products on FP10/GP10. Direct competitor in NHS prescribable ONS and adjacent specialised nutrition.
• Nualtra: Irish-founded ONS company producing compact and powdered oral nutritional supplements (e.g., Aymes-adjacent formats) prescribed across UK and Ireland. Comparable in product format, pricing strategy, and NHS distribution.

Broad incumbents

• Abbott Nutrition: Global healthcare giant with Ensure and Vital ONS ranges competing in the UK malnutrition market. Broader portfolio spanning pharmaceuticals, diagnostics, and nutrition creates overlap with AYMES in ONS.
• Nestlé Health Science: Health-focused arm of Nestlé marketing Resource and Peptamen ONS, prominent in UK NHS prescribing. Comparable in addressing disease-related malnutrition with a wider portfolio and global R&D.
• Mead Johnson (Reckitt): Specialised nutrition subsidiary of Reckitt producing paediatric and metabolic nutrition products. Comparable in clinical nutrition positioning and ACBS-style prescribing channels.

Emerging players

• Kate Farms: US-based plant-based medical nutrition company with oral and tube-feed formulas. Comparable in addressing disease-related malnutrition with plant-based formulations, though primarily US distribution.
• Abbott (Paediatric Nutrition): Abbott's paediatric nutrition line (PediaSure, Similac) competes with AYMES' ActaJuni range in ACBS-approved feeds for children. Overlaps in paediatric ONS segment but broader paediatric scope.

Others

• Arla Foods Ingredients: B2B supplier of whey protein, milk minerals, and specialised dairy nutrition ingredients used in medical nutrition including ONS. Comparable as upstream supplier in the specialised dairy nutrition value chain.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AYMES